The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 29, 2012

Conditions
Brain TumorAVMICH
Interventions
DRUG

remifentanil

"According to previous patient's response, the investigators will allocate the effect site concentration of remifentanil of next patient during head fixation. And, For this allocation of dose of remifentanil the investigators use biased coin design up-and-down method.~For the first patient, the dose of remifentanil would be fixed at 5.5ng/ml which we predict as EC90. And, step size of dose is 0.5ng/ml."

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01489137 - The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation | Biotech Hunter | Biotech Hunter